论文部分内容阅读
Background Despite significant pharmacological and mechanical advancements in PCI, The optimal value of activated clotting time (ACT) during percutaneous coronary intervention (PCI) with unfractionated heparin remains controversial.No data are available on the relation between the ACT at the end of the procedure (final ACT) and the clinical outcomes after transradial PCI.